Navigation Links
Scientists discover key event in prostate cancer progression
Date:7/23/2009

COLUMBUS, Ohio A study led by researchers at the Ohio State University Comprehensive Cancer Center and Dana-Farber Cancer Institute reveals how late-stage, hormone-independent prostate tumors gain the ability to grow without need of hormones.

The onset of hormone-independent growth marks an advanced and currently incurable stage of prostate cancer.

The study, published in the July 24, 2009, issue of the journal Cell, focuses on androgen receptors, molecules located in the nucleus of cells of the prostate gland and other tissues. Male sex hormones androgens bind with these receptors to activate genes that control cell growth.

The researchers show that in androgen-independent prostate cancer, androgen receptors are reprogrammed to regulate a group of genes involved in a different, later, phase of cell division, triggering rapid cell growth. They further show that a modification of a chief component of the chromosome is responsible for this reprogramming.

"Some late-phase prostate cancer does not require androgen hormones for tumor growth, but it does require androgen receptors," says first author and co-corresponding author Qianben Wang, assistant professor of molecular and cellular biochemistry and a researcher with the Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

"Our study reveals the role of androgen receptors in hormone independent prostate cancer, how they become active in that disease and what genes they regulate to promote tumor growth."

The findings provide a better understanding of prostate cancer and could identify new therapeutic targets and lead to new treatments for this lethal stage of the disease, he says.

Prostate cancer is the most frequently diagnosed cancer in men. An estimated 192,280 new cases are expected in the United States in 2009, along with 27,360 deaths from the disease.

To conduct the study, Wang working with correspondin
'/>"/>

Contact: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Scientists Use Non-Embryonic Stem Cells to Create Healthy Mice
2. Scientists Use Adult Stem Cells to Create Healthy Mice
3. Scientists locate disease switches
4. Scientists Reverse Muscular Dystrophy in Mice
5. St. Jude Scientists Discover a New Mechanism Controlling Neuronal Migration
6. Addiction scientists call for end to executions for drug offenders
7. UCLA scientists identify how immune cells may help predict Alzheimers risk
8. Six Scientists Receive Awards for Contributions to Alzheimers Disease Research
9. 6 scientists receive awards for contributions to Alzheimers disease research
10. Two Fred Hutchinson Cancer Research Center Scientists Receive Presidential Early Career Award
11. Scientists Zero In on Elusive Allergy Gene
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Onyx Pharmaceuticals, ... safety data from the pivotal Phase 2b 003-A1 ... carfilzomib is well-tolerated in heavily pre-treated relapsed and ... today at the ASH/ASCO Joint Symposium at the ... Hematology (ASH) in New Orleans. Enrollment in this ...
(Date:12/6/2009)... Disorders information and Treatment site www.sleeping-with-a-sleeping-disorder.com ... with herbal or natural sleep aids from around ... for a good cause. The submissions will be ... Aids ,Encyclopedia, by YOU, to be sold from ... will donate 100% of the proceeds ,from sales ...
(Date:12/5/2009)... 5 There have been significant scientific advances in ... to gain a better understanding of how certain diseases ... provide patients with the best care. Research presented today ... of Hematology explores optimal induction therapies for managing multiple ...
(Date:12/5/2009)... myeloproliferative disorders are serious and often deadly blood ... Meeting of the American Society of Hematology introduces ... for patients suffering from acute promyelocytic leukemia, chronic ... that are based on a better understanding of ...
(Date:12/5/2009)... today announced the launch of International Solutions, an innovative new international ... its UK equivalent. In addition to offering customers the flexibility to ... needs and budgets, International Solutions enables customers to tailor their benefits ... , ...
Breaking Medicine News(10 mins):Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2
... positive results, ROSEMONT, Ill., Nov. 3 ... condition known as clubfoot,have similarly high levels of ... November 2008 issue of The Journal of Bone ... strategies use different,approaches, each brings positive outcomes for ...
... EL SEGUNDO, Calif., Nov. 3 The ... only national organization creating hope in a,comprehensive ... and,advocacy for a cure, launches Raise Your ... Pancreatic,Cancer Awareness Month. Raise Your Voice and ...
... The Zon hearing aid, designed by,Stuart Karten Design for ... presented by the Smithsonian,s Cooper-Hewitt, National Design,Museum., At ... New,York on Oct. 23, Padma Lakshmi, host of Bravo,s ... to Stuart Karten., "In developing Zon, we sought ...
... Group, the,premier strategic interactive marketing agency serving the ... Deloitte,s prestigious Fast,50 Program for Greater Philadelphia - ... and life sciences companies in the,area by Deloitte ... Rankings are based on the percentage revenue growth ...
... "When my father was formally,diagnosed with Alzheimer,s in ... article I could get my hands on," writes Michele ... (published by,AuthorHouse -- http://www.authorhouse.com ). "Educate, educate, educate ... that once I knew the facts, I,could get the ...
... trend, researchers say , , MONDAY, Nov. 3 (HealthDay ... United States is dramatically increasing as more kids ... hyperactivity disorder (ADHD), researchers report. , Increased prescribing ... obesity among children and the health consequences of ...
Other Medicine News:Health News:Non-Surgical Clubfoot Treatments Bring High Level of Success 2Health News:Non-Surgical Clubfoot Treatments Bring High Level of Success 3Health News:Join the Pancreatic Cancer Action Network and Raise Your Voice in November for Pancreatic Cancer Awareness Month 2Health News:Join the Pancreatic Cancer Action Network and Raise Your Voice in November for Pancreatic Cancer Awareness Month 3Health News:Stuart Karten Design's Zon Hearing Aid Wins 2008 Cooper-Hewitt People's Design Award 2Health News:Stuart Karten Design's Zon Hearing Aid Wins 2008 Cooper-Hewitt People's Design Award 3Health News:Cadient Group Ranked 34th in Deloitte's Fast 50 Program for Greater Philadelphia 2Health News:'A Conversation About Alzheimer's': Woman Shares Story of Love, Hope, Loss and Survival in New Book About Alzheimer's Disease 2Health News:Use of Kids' Meds on the Increase 2Health News:Use of Kids' Meds on the Increase 3
(Date:12/4/2009)... Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC ... and Trademark Office has allowed its patent application on ... the manufacture of the Company,s DCVax® therapeutic cancer vaccines. ... very high concentration of dendritic cells (which are the ...
(Date:12/4/2009)... N.J., Dec. 4 Depression, anxiety disorder, bipolar ... and migraine: These are among the comorbidities reported ... they had been diagnosed with epilepsy versus those ... of approximately 173,000 households across the U.S. ,, ...
(Date:12/3/2009)... ACTON, Mass., Dec. 3 Allen Medical Systems, a ... ), today announced the launch of its new Allen ... www.AllenAmatech.com . ,, The website reinforces the ... of the new product catalog, with detailed descriptions and ...
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Evolvent Awarded Health Information Exchange Contract 13638 1Evolvent Awarded Health Information Exchange Contract 13638 2Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 1Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 2Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 3LSTM to lead EU project to coordinate antimalarial drug research 54952 1LSTM to lead EU project to coordinate antimalarial drug research 54952 2
... Pa., May 4 Just hours after the World ... pandemic is imminent, a prominent insurance law firm announced ... to address this urgent global risk."As we,ve seen with ... financial crisis, the insurance industry plays an enormously important ...
... 12-week study concludes that new cosmeceutical improves skin barrier ... May 4 Senetek PLC (OTC Bulletin ... development of technologies that target the science of healthy ... PRK-124 (0.125%) Lotion for Improving the Signs and Symptoms ...
Other Medicine Technology:Insurance Industry Teleconference on Swine Flu Pandemic Set for May 13 2Spotlight on Rosacea Advance - May Issue of Journal of Drugs in Dermatology Features Pyratine XR(TM) Clinical Study 2